These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
40 related items for PubMed ID: 16765697
1. Photodynamic therapy of subfoveal choroidal neovascularization secondary to reticular pattern dystrophy: three-year results of an uncontrolled, prospective case series. Parodi MB, Liberali T, Pedio M, Francis PJ, Piccolino FC, Fiotti N, Romano M, Ravalico G. Am J Ophthalmol; 2006 Jun; 141(6):1152-4. PubMed ID: 16765697 [Abstract] [Full Text] [Related]
2. Photodynamic therapy vs limited macular translocation in the management of subfoveal choroidal neovascularization in pathologic myopia: a two-year study. Glacet-Bernard A, Benyelles N, Dumas S, Haddad WM, Voigt M, Razavi S, Roquet W, Coscas G, Soubrane G. Am J Ophthalmol; 2007 Jan; 143(1):68-76. PubMed ID: 17188042 [Abstract] [Full Text] [Related]
3. Photodynamic therapy for nonsubfoveal choroidal neovascularization in 100 eyes with pathologic myopia. Virgili G, Varano M, Giacomelli G, Arena MC, Tedeschi M, Pascarella A, Catalano S, Menchini U. Am J Ophthalmol; 2007 Jan; 143(1):77-82. PubMed ID: 17188043 [Abstract] [Full Text] [Related]
4. Retinal pigment epithelial tear following photodynamic therapy for choroidal neovascularization secondary to AMD. Goldstein M, Heilweil G, Barak A, Loewenstein A. Eye (Lond); 2005 Dec; 19(12):1315-24. PubMed ID: 15803179 [Abstract] [Full Text] [Related]
5. Efficacy of photodynamic therapy in the management of occult choroidal neovascularization associated with serous pigment epithelium detachment. Ladas ID, Kotsolis AI, Rouvas AA, Brouzas D, Moschos MM. Ophthalmologica; 2007 Dec; 221(5):313-9. PubMed ID: 17728553 [Abstract] [Full Text] [Related]
6. Clinical course and treatment outcomes of Sorsby fundus dystrophy. Sivaprasad S, Webster AR, Egan CA, Bird AC, Tufail A. Am J Ophthalmol; 2008 Aug; 146(2):228-234. PubMed ID: 18501328 [Abstract] [Full Text] [Related]
8. Twelve-month safety and visual acuity results from a feasibility study of intraocular, epiretinal radiation therapy for the treatment of subfoveal CNV secondary to AMD. Avila MP, Farah ME, Santos A, Kapran Z, Duprat JP, Woodward BW, Nau J. Retina; 2009 Feb; 29(2):157-69. PubMed ID: 19202425 [Abstract] [Full Text] [Related]